DE4CC0DE-5FC3-4494-BCBF-4D50B00366B5

Drug Retailer Rite Aid's Revenue Misses Estimates

By Publications Checkout
Share this article
Drug Retailer Rite Aid's Revenue Misses Estimates

Drug retailer Rite Aid, which is being bought by US grocer Albertsons Cos. Inc., posted smaller-than-expected fourth-quarter revenue, hurt by a decline in reimbursement rates and prescription volumes.

Revenue fell to $5.39 billion from $5.90 billion, missing the average analyst estimate of $5.57 billion, according to Thomson Reuters I/B/E/S.

The company posted net loss from continuing operations of $483.7 million, or 46 cents per share, for the quarter ended 3 March, compared with a loss of $25.1 million, or 2 cents per share, a year earlier.

The loss includes $325 million of income tax expense related mainly to the revaluation of the company's deferred tax assets in connection with the new US tax law.

Excluding one-time items, Rite Aid reported a loss of 1 cent per share.

News by Reuters, edited by ESM. Click subscribe to sign up to ESM: European Supermarket Magazine. 

ADVERTISEMENT
Get the week's top grocery retail news

The most important stories from European grocery retail direct to your inbox every Thursday

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our terms & conditions and privacy policy. You can unsubscribe at any time.